Poster #48 A MUTLIMODAL STUDY OF EMOTION PROCESSING IN PRODROMAL AND FIRST-EPISODE PSYCHOSIS (original) (raw)
Related papers
Current Topics in Medicinal Chemistry, 2012
Maarten Koeter, Chaim Huyser, Dick Veltman
Journal of psychiatry & neuroscience : JPN, 2014
Schizophrenia, substance use, and brain morphology
Schizophrenia Research, 1999
Schizophrenia Research, 2016
Schizophrenia Research, 2014
White matter microstructure in schizophrenia: effects of disorder, duration and medication
The British Journal of Psychiatry, 2009
Christopher Hanstock, Sherry Stewart, Denise Bernier
BMC Psychiatry, 2013
Factors Associated With Brain Heterogeneity in Schizophrenia—Reply
JAMA Psychiatry, 2019
Schizophrenia Research, 2008
2012
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
European Archives of Psychiatry and Clinical Neuroscience, 2013
Dhruman Goradia, Debra Montrose, Srihari Bangalore
Schizophrenia research, 2008
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Journal of Visualized Experiments, 2020
White matter volume abnormalities and associations with symptomatology in schizophrenia.
Psychiatry …, 2010
White matter volume changes in people who develop psychosis
2008
Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia
Schizophrenia Research, 2007
Cerebellar white-matter changes in cannabis users with and without schizophrenia
Psychological Medicine, 2011
Alterations in White Matter Evident Before the Onset of Psychosis
Schizophrenia bulletin, 2012
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia
The British Journal of Psychiatry, 2007
…, 2007
American Journal of Psychiatry, 2007
2019
White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
Neuropsychopharmacology, 2013
Schizophrenia and the brain: a prospective clinico-neuropathological study
Psychological Medicine, 1990
Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia
European Neuropsychopharmacology, 2009